Board

Laxminarayan Bhat, Ph.D.

IMG_11032015_205815Laxminarayan Bhat is the Founder, President and Chief Executive Officer of Reviva Pharmaceuticals, Inc. Dr. Bhat founded Reviva in 2006 and since its inception, the company has advanced rapidly under his leadership, with a portfolio of propriety compounds at different stages in a pipeline encompassing chronic diseases in large therapeutic areas such as CNS, metabolic, cardiovascular and pain. Dr. Bhat has developed and implemented innovative financing and business models with strategies that have greatly accelerated the drug discovery and development process, resulting in significant savings of time and costs but without sacrificing quality.

Dr. Bhat has over 18 years’ experience in drug discovery and development and prior to founding Reviva, he held research positions at XenoPort, ARYx Therapeutics and Higuchi Biosciences Center in the United States. Dr. Bhat has received a global post-doctoral training at the University of Kansas, USA, the Georg-August-Universität, Göttingen, Germany and the Université du Maine, France. In 1995, he was selected for the Alexander von Humboldt fellowship, an internationally recognized award for young scientists to pursue advanced research in Germany. Dr. Bhat received his Ph.D. in synthetic organic chemistry from the Central University (NEHU), India and has authored over 15 research papers published in peer-reviewed scientific journals. Dr. Bhat is an inventor on more than 100 filed patents and over 35 granted patents.

Purav Patel

Purav PatelPurav is the Founder and Managing Partner of Buena Vista Fund I, and also, a Serial Entrepreneur with 10+ years in active advisory, board, and fund-raising roles for 15+ privately held companies in various stages in healthcare and other fields. Purav served on the board of his portfolio companies, Healthify and Bindo. Purav has been with Reviva as an investor since 2009, and has a deep understanding of where the company has come from. Purav has worked directly with the Reviva management to secure funding over 4 investment rounds. Purav is highly analytical with a strong background in due diligence, financial analysis, and business operations. Purav graduated from the University of Texas with a Bachelors in Biology and Business.

Bradley G Thompson, Ph.D.

IMG_11032015_205815Dr. Thompson is an experienced biotechnology founder and public company executive having held the positions of Chairman, President and CEO of Oncolytics Biotech, Inc., from 1999 to 2016 and CEO of Synsorb Biotech from 1994 to 1999. Dr. Thompson also is currently a Board member of Aptose Biosciences Inc. He has served as Chairman, Director and Audit Committee member on a number of other public company (NASDAQ, TSX, CDNX) boards of directors, and has served as a Director of private company boards and industry groups (including Chairman and Chairman Emeritus of BIOTECanada). He received his Ph.D. from the University of Western Ontario in the Department of Microbiology and Immunology.

TOP